Sanofi (SNY) Total Debt (2009 - 2026)

Sanofi has disclosed Total Debt across 18 years of filings, most recently posting $25.2 billion for Q2 2026.

• In Q2 2026, Total Debt rose 8.51% year-over-year to $25.2 billion; the TTM figure through Jun 2026 stood at $25.2 billion (up 8.51% YoY), while the FY2025 annual figure was $21.6 billion, up 24.96% from the prior year.
• Total Debt came in at $25.2 billion for Q2 2026 at Sanofi, up from $21.6 billion in the prior quarter.
• In the past five years, Total Debt ranged from a high of $25.2 billion in Q2 2026 to a low of $17.1 billion in Q4 2024.
• Average Total Debt over 5 years is $20.9 billion, with a median of $20.6 billion recorded in 2023.
• Year-over-year, Total Debt fell 16.47% in 2022 and rose 26.57% in 2025.
• Over 5 years, Total Debt stood at $19.4 billion in 2022, then fell by 9.17% to $17.6 billion in 2023, then declined by 3.06% to $17.1 billion in 2024, then increased by 26.57% to $21.6 billion in 2025, then increased by 16.41% to $25.2 billion in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $25.2 billion in Q2 2026, $21.6 billion in Q4 2025, and $23.2 billion in Q2 2025.